Questcor Pharmaceuticals Sends Cease and Desist Letter to Access Securities -8K

On August 13, 2012, Questcor Pharmaceuticals, Inc.'s

outside counsel delivered, on behalf of Questcor, a letter (the "Cease and Desist Letter") to Access Securities, LLC and Access Securities, LP (collectively, "Access Securities"), requesting that Access Securities cease and desist from engaging in defamation, placing Questcor in a false light, tortious interference with Questcor's economic advantage, and unfair business practices. Questcor alleges that this tortious conduct occurred in connection with an announcement made by Access Securities relating to a scheduled and later cancelled investor conference call. It is possible that Questcor will decide to take further action in connection with this matter, which action could include one or more of the following: (a) bringing a lawsuit against Access Securities for defamation, false light, tortious interference, and unfair business practices, among other claims; (b) referring the above matter to the Securities and Exchange Commission and/or the California Department of Corporations for enforcement action; and (c) seeking monetary damages, injunctive relief, and attorneys' fees against Access Securities and any person associated with or employed by Access Securities who has participated in Access Securities' unlawful conduct. Questcor undertakes no obligation to publicly disclose any update regarding this matter.